Background illustration for clinical trials search

Paid Clinical Trials San Jose

Discover 2,242 paid clinical trials in San Jose, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia

for
Acute Lymphoblastic Leukemia
Location: Stanford CA, Duarte CA, Basking Ridge NJ, Montvale NJ,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 40+

Code: NCT07400029

Phase 2, Recruiting

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

for
Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
Location: Stanford CA, San Francisco CA, Los Angeles CA,
Sponsor: Alkermes, Inc.

Sex: All

Age: 18 - 70

Code: NCT06767683

Phase 2, Phase 3, Recruiting

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis,
Location: Stanford CA, Tucson AZ, Little Rock AR, Canoga Park CA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18 - 70+

Code: NCT06318169

Phase 3, Recruiting

A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)

for
Neoplasms
Location: Stanford CA, West Valley City UT, Denver CO,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06551142

Phase 1, Recruiting

Study of External Neuromodulation to Improve Signs and Symptoms of Dry Eye in Visual Display Terminal Users

for
Visual Display Users With Previously Undiagnosed Dry Eye
Location: Palo Alto CA
Sponsor: Olympic Ophthalmics, Inc.

Sex: All

Age: 18 - 69

Code: NCT04763018

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

for
Atopic Dermatitis
Location: Palo Alto CA, Sacramento CA, San Diego CA, Portland OR,
Sponsor: LEO Pharma

Sex: All

Age: 0 - 11

Code: NCT06311682

Phase 3, Recruiting

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

for
Ulcerative Colitis (UC)
Location: Palo Alto CA, Montreal, Scottsdale AZ, Vancouver,
Sponsor: Xencor, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06619990

Phase 1, Phase 2, Recruiting

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

for
Ulcerative Colitis, Crohn Disease
Location: Palo Alto CA, Los Angeles CA, Irvine CA, La Jolla CA,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05230173

Recruiting

A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

for
Parkinson Disease
Location: Palo Alto CA, Aliso Viejo CA, Tulsa OK, Dallas TX,
Sponsor: Impax Laboratories, LLC

Sex: All

Age: 18+

Code: NCT06765668

Recruiting

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

for
Parkinson Disease, Parkinson, Idiopathic Parkinson Disease,
Location: Palo Alto CA, Sacramento CA, Fresno CA, Los Angeles CA,
Sponsor: Neuron23 Inc.

Sex: All

Age: 40 - 70+

Code: NCT06680830

Phase 2, Recruiting

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

for
Parkinson's Disease
Location: Palo Alto CA, Stanford CA, San Francisco CA, Reno NV,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 50 - 70+

Code: NCT07174310

Phase 3, Recruiting

Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:

for
Parkinson Disease
Location: Palo Alto CA, Aliso Viejo CA, Irvine CA, Boca Raton FL,
Sponsor: Supernus Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07219927

Recruiting
New

Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)

for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Palo Alto CA, Berkeley CA, Sacramento CA, Post Falls ID,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT07393555

Phase 2, Recruiting

Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)

for
Hepatitis
Location: Palo Alto CA, Redwood City CA, Sacramento CA,
Sponsor: Bausch Health Americas, Inc.

Sex: All

Age: 18+

Code: NCT07428538

Phase 3, Recruiting

BOOM-IBD2 Pivotal Clinical Trial

for
Ulcerative Colitis, Inflammatory Bowel Diseases
Location: Palo Alto CA, Folsom CA, Los Angeles CA,
Sponsor: Boomerang Medical

Sex: All

Age: 18 - 70+

Code: NCT06571669

Recruiting

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

for
Ovarian Cancer
Location: Palo Alto CA, Burbank CA, La Jolla CA, Portland OR,
Sponsor: Daiichi Sankyo

Sex: Female

Age: 18+

Code: NCT06819007

Phase 3, Recruiting

FreeStyle Libre 2 Discharge Trial

for
Diabetes Mellitus, Type 2, Hypoglycemia
Location: Palo Alto CA, Atlanta GA
Sponsor: Palo Alto Medical Foundation

Sex: All

Age: 18+

Code: NCT05822232

Recruiting

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

for
Urothelial Cancer
Location: Palo Alto CA, San Francisco CA, Sacramento CA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07106762

Phase 2, Phase 3, Recruiting

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Location: Palo Alto CA, San Francisco CA, Greenbrae CA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06793215

Phase 3, Recruiting

A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Palo Alto CA, Duarte CA, Irvine CA, Henderson NV,
Sponsor: Loxo Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06588478

Phase 2, Recruiting